Schuringa JJ - Search Results

1

Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.

de Boer B, Prick J, Pruis MG, Keane P, Imperato MR, Jaques J, Brouwers-Vos AZ, Hogeling SM, Woolthuis CM, Nijk MT, Diepstra A, Wandinger S, Versele M, Attar RM, Cockerill PN, Huls G, Vellenga E, Mulder AB, Bonifer C, Schuringa JJ. de Boer B, et al. Among authors: schuringa jj. Cancer Cell. 2018 Oct 8;34(4):674-689.e8. doi: 10.1016/j.ccell.2018.08.014. Epub 2018 Sep 20. Cancer Cell. 2018. PMID: 30245083 Free article.

2

Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.

Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E. Schuringa JJ, et al. Blood. 2000 Jun 15;95(12):3765-70. Blood. 2000. PMID: 10845908 Free article.

3

LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.

Schuringa JJ, van der Schaaf S, Vellenga E, Eggen BJ, Kruijer W. Schuringa JJ, et al. Exp Cell Res. 2002 Mar 10;274(1):119-29. doi: 10.1006/excr.2001.5454. Exp Cell Res. 2002. PMID: 11855863 Free article.

4

Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.

Wierenga AT, Schuringa JJ, Eggen BJ, Kruijer W, Vellenga E. Wierenga AT, et al. Among authors: schuringa jj. Leukemia. 2002 Apr;16(4):675-82. doi: 10.1038/sj.leu.2402425. Leukemia. 2002. PMID: 11960349

5

Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.

Benus GF, Wierenga AT, de Gorter DJ, Schuringa JJ, van Bennekum AM, Drenth-Diephuis L, Vellenga E, Eggen BJ. Benus GF, et al. Among authors: schuringa jj. Mol Biol Cell. 2005 Aug;16(8):3501-10. doi: 10.1091/mbc.e04-11-1033. Epub 2005 May 25. Mol Biol Cell. 2005. PMID: 15917296 Free PMC article.

6

STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha.

Wierenga AT, Schepers H, Moore MA, Vellenga E, Schuringa JJ. Wierenga AT, et al. Among authors: schuringa jj. Blood. 2006 Jun 1;107(11):4326-33. doi: 10.1182/blood-2005-11-4608. Epub 2006 Feb 2. Blood. 2006. PMID: 16455947 Free article.

7

Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?

Rizo A, Vellenga E, de Haan G, Schuringa JJ. Rizo A, et al. Among authors: schuringa jj. Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R210-9. doi: 10.1093/hmg/ddl175. Hum Mol Genet. 2006. PMID: 16987886 Review.

8

Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.

Schepers H, Wierenga AT, van Gosliga D, Eggen BJ, Vellenga E, Schuringa JJ. Schepers H, et al. Among authors: schuringa jj. Blood. 2007 Aug 15;110(4):1317-25. doi: 10.1182/blood-2006-10-052175. Epub 2007 May 2. Blood. 2007. PMID: 17475913 Free article.

9

Expansion of normal and leukemic human hematopoietic stem/progenitor cells requires rac-mediated interaction with stromal cells.

Rozenveld-Geugien M, Baas IO, van Gosliga D, Vellenga E, Schuringa JJ. Rozenveld-Geugien M, et al. Among authors: schuringa jj. Exp Hematol. 2007 May;35(5):782-92. doi: 10.1016/j.exphem.2007.02.006. Exp Hematol. 2007. PMID: 17577927 Free article.

10

STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.

Schepers H, van Gosliga D, Wierenga AT, Eggen BJ, Schuringa JJ, Vellenga E. Schepers H, et al. Among authors: schuringa jj. Blood. 2007 Oct 15;110(8):2880-8. doi: 10.1182/blood-2006-08-039073. Epub 2007 Jul 13. Blood. 2007. PMID: 17630355 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page